Advertisement
Advertisement
U.S. Markets close in 2 hrs 49 mins
Advertisement
Advertisement
Advertisement
Advertisement

Panbela Therapeutics, Inc. (PBLA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4000+0.0300 (+2.19%)
As of 12:57PM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/8/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.5400
52 Week Low 30.5910
50-Day Moving Average 31.1964
200-Day Moving Average 31.7071

Share Statistics

Avg Vol (3 month) 345.6k
Avg Vol (10 day) 319.95k
Shares Outstanding 513.43M
Implied Shares Outstanding 6N/A
Float 811.94M
% Held by Insiders 19.72%
% Held by Institutions 14.08%
Shares Short (Jul 14, 2022) 4175.25k
Short Ratio (Jul 14, 2022) 41.66
Short % of Float (Jul 14, 2022) 40.89%
Short % of Shares Outstanding (Jul 14, 2022) 40.84%
Shares Short (prior month Jun 14, 2022) 4153.54k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 07, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:1
Last Split Date 3Dec 07, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-73.60%
Return on Equity (ttm)-162.99%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-11.54M
Diluted EPS (ttm)-0.6950
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.39M
Total Cash Per Share (mrq)0.55
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.76
Book Value Per Share (mrq)1.00

Cash Flow Statement

Operating Cash Flow (ttm)-9.22M
Levered Free Cash Flow (ttm)-2.6M
Advertisement
Advertisement